The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...